Latest California Healthline Stories
Early Detection May Help Kentucky Tamp Down Its Lung Cancer Crisis
After a decade of work, a Kentucky program launched to diagnose lung cancer earlier is beginning to change the prognosis for residents by catching tumors when they’re more treatable.
Patients See First Savings From Biden’s Drug Price Push, as Pharma Lines Up Its Lawyers
A restructuring of the Medicare drug benefit has wiped out big drug bills for people who need expensive medicines. But the legal battle over drug negotiations means uncertainty over long-term savings.
FDA Move to Ban Hair Relaxer Chemical Called Too Little, Too Late
The FDA’s recent notice that it would move to ban formaldehyde in hair-straightening products comes more than a decade after researchers raised alarms about health risks. Scientists say a ban would still leave many dangerous chemicals in hair straighteners.
La FDA finalmente prohibiría peligroso químico en productos para alisar el cabello
El primer estudio que vinculó los alisadores de cabello con el cáncer de útero, publicado en 2022, encontró que el uso frecuente de estos químicos duplica con creces el peligro.
Hoping to Clear the Air in Casinos, Workers Seek to Ban Tobacco Smoke
Casinos in several states are fighting efforts to ban smoking, and trying to roll back existing anti-smoking laws. One planned facility even moved outside a city’s limits because of voter-approved smoking restrictions.
Mammography AI Can Cost Patients Extra. Is It Worth It?
Artificial intelligence software to aid radiologists in detecting problems or diagnosing cancer has been moving rapidly into clinical use, where it shows great promise. But it’s a turnoff for some patients asked to pay out-of-pocket for technology that’s not quite ready for prime time.
Mamografías que usan inteligencia artificial cuestan dinero extra… pero, ¿vale la pena?
Este software puede identificar patrones y anomalías que los radiólogos humanos podrían pasar por alto. Pero no es el estándar de atención.
Cancer Patients Face Frightening Delays in Treatment Approvals
Delaying cancer treatment can be deadly — which makes the roadblock-riddled process that health insurers use to approve or deny care particularly daunting for oncology patients.
Suzanne Somers’ Legacy Tainted by Celebrity Medical Misinformation
The popular actress and author, who died this week, also can be remembered as a progenitor of selling dubious medical information to a trusting public.
She Received Chemo in Two States. Why Did It Cost So Much More in Alaska?
A breast cancer patient who received similar treatments in two states saw significant differences in cost, illuminating how care in remote areas can come with a stiffer price tag.